Arbianti Novita, Prihatiningsih Septiyani, Indriani Dwi Wahyu, Indriati Dwi Wahyu
BSc, Team of Antimicrobial Resource Alternative Studies for Emerging and Re-emerging Infectious Disease Research Group, Department of Health, Faculty of Vocational Studies, Universitas Airlangga, Dharmawangsa Dalam Selatan no 28-30, Surabaya, 60286, East Java, Indonesia.
MD, Clinical Microbiologist, Team of Microbiology Laboratory, Haji General Hospital, Surabaya, 60116, East Java, Indonesia.
Germs. 2020 Sep 1;10(4):157-166. doi: 10.18683/germs.2020.1201. eCollection 2020 Sep.
Diabetes mellitus (DM) is a metabolic disease that can cause many complications. The occurrence of urinary tract infection is also considered to be the cause of complications in patients with DM. This study aimed to evaluate the prevalence of urinary tract infection (UTI) and antibiotic-resistant bacteria found in urine culture from patients with DM in Surabaya, Indonesia.
This study was conducted with a retrospective cross-sectional study design, using a database of 1551 patients with DM admitted to Haji Hospital, Surabaya, Indonesia, from January 2017 to December 2018. Data regarding the bacteria isolated from urine and antimicrobial sensitivity were analyzed.
The prevalence of UTI was 3.93% - 61 patients were confirmed with urine culture for UTI diagnosis. The predominant isolates found were (24.5%) and (8%). This study also showed multidrug-resistant organisms (MDRO) found in UTI such as MDRO (3.3 %), MDRO (3.3%), MDRO (1.6%), extended-spectrum beta-lactamase (ESBL) (3.3%). The were sensitive to fosfomycin (93%), meropenem (93%) and nitrofurantoin (67%). No significant difference in the prevalence of UTI was found among ages, sex, and duration of disease in all patients with DM.
The cases of UTI seen in patients with DM show the importance of monitoring UTI occurrence in this patient category to ensure better treatment for these patients.
糖尿病(DM)是一种可引发多种并发症的代谢性疾病。尿路感染的发生也被认为是糖尿病患者并发症的成因之一。本研究旨在评估印度尼西亚泗水市糖尿病患者尿培养中尿路感染(UTI)的患病率以及发现的耐药菌情况。
本研究采用回顾性横断面研究设计,使用了2017年1月至2018年12月期间入住印度尼西亚泗水哈吉医院的1551例糖尿病患者的数据库。对从尿液中分离出的细菌及抗菌药敏数据进行了分析。
尿路感染的患病率为3.93%——61例患者经尿培养确诊为尿路感染。发现的主要分离菌为(24.5%)和(8%)。本研究还显示在尿路感染中发现了多重耐药菌(MDRO),如MDRO(3.3%)、MDRO(3.3%)、MDRO(1.6%)以及超广谱β-内酰胺酶(ESBL)(3.3%)。这些细菌对磷霉素(93%)、美罗培南(93%)和呋喃妥因(67%)敏感。在所有糖尿病患者中,年龄、性别和病程方面尿路感染患病率无显著差异。
糖尿病患者中出现的尿路感染病例表明,监测该类患者尿路感染的发生情况对于确保为这些患者提供更好的治疗具有重要意义。